Biotech Co. Execs Charged In $12.7M Painkiller Fraud
The chief executive of a small Boston-born biotech company and two associates were arrested on Tuesday and charged with fraudulently raising about $12.7 million on false prospects of a time-release painkiller...To view the full article, register now.
Already a subscriber? Click here to view full article